The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases
Authors
Keller, Martin B.Trivedi, Madhukar H.
Thase, Michael E.
Shelton, Richard C.
Kornstein, Susan G.
Nemeroff, Charles B.
Friedman, Edward S.
Gelenberg, Alan J.
Kocsis, James H.
Dunner, David L.
Hirschfeld, Robert M.
Rothschild, Anthony J.
Ferguson, James M.
Schatzberg, Alan F.
Zajecka, John M.
Pedersen, Ronald D.
Yan, Bing
Ahmed, Saeeduddin
Musgnung, Jeff
Ninan, Philip T.
UMass Chan Affiliations
Department of PsychiatryDocument Type
Journal ArticlePublication Date
2007-09-15Keywords
AdultAntidepressive Agents, Second-Generation
effects
Cyclohexanols
Delayed-Action Preparations
Depressive Disorder
Dizziness
Double-Blind Method
Female
Fluoxetine
Gastrointestinal Diseases
Headache
Humans
Hypertension
Male
Middle Aged
Recurrence
Respiratory Tract Infections
Treatment Outcome
Psychiatry